Stock Analiz

Vanda Pharmaceuticals Inc. (VNDA) stock forecast and price target

Price $3.99 · data as of November 13, 2026

12-month price target

Average target$11.50
Upside / downside+188.2%
Analysts5
ConsensusStrong buy
Low $4.50Average $11.50High $20.00

Gold marker: average target · white marker: today’s price ($3.99)

Analyst ratings

Strong buy 0Buy 4Hold 1Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-2.52—$242M
Next fiscal year
ends December 31, 2027
$-0.74—$316M
Next quarter
ends December 31, 2026
$-0.30—$70M
Quarter after
ends March 31, 2027
$-0.25—$72M

Consensus of the analysts covering Vanda Pharmaceuticals, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Frequently asked questions

What is the Vanda Pharmaceuticals stock price target?

The average 12-month target from 5 analysts is $11.50, 188.2% above the current price of $3.99 Targets range from $4.50 to $20.00.

Is Vanda Pharmaceuticals a buy according to analysts?

The consensus rating is “Strong buy” (4 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Vanda Pharmaceuticals expected to earn?

Analysts expect EPS of $-2.52 for the fiscal year ending December 31, 2026 and $-0.74 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.